Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15289445rdf:typepubmed:Citationlld:pubmed
pubmed-article:15289445lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:15289445lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:15289445lifeskim:mentionsumls-concept:C0003483lld:lifeskim
pubmed-article:15289445lifeskim:mentionsumls-concept:C0040711lld:lifeskim
pubmed-article:15289445lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:15289445lifeskim:mentionsumls-concept:C0020456lld:lifeskim
pubmed-article:15289445lifeskim:mentionsumls-concept:C0380603lld:lifeskim
pubmed-article:15289445lifeskim:mentionsumls-concept:C1512886lld:lifeskim
pubmed-article:15289445pubmed:issue13lld:pubmed
pubmed-article:15289445pubmed:dateCreated2004-10-6lld:pubmed
pubmed-article:15289445pubmed:abstractTextFibroblast growth factor 2 (FGF-2) is normally synthesized at low levels but is elevated in various pathophysiological conditions including diabetes-associated vascular diseases. FGF-2 expression is regulated translationally through an internal ribosome entry site (IRES) located in its mRNA, which allows a nonclassical cap-independent translation. We addressed the pathophysiological regulation of the IRES in vivo by using a streptozotocin-induced hyperglycemic model known to suppress markedly overall translation. Evaluation of FGF-2 IRES-dependent translation was performed with transgenic mice expressing dual luciferase bicistronic mRNA containing the FGF-2 IRES. FGF-2 IRES-dependent reporter activity increased 240% of control in the diabetic aorta although the reporter mRNA levels significantly decreased. Expression of endogenous FGF-2 protein in the aorta closely correlated with the IRES activity but not with FGF-2 mRNA levels. Moreover, the biosynthesis of endogenous FGF-2 protein was stimulated in an IRES-dependent manner by high glucose that significantly suppressed global protein synthesis in aortic smooth muscle cells from the transgenic mice. These results suggest that IRES-dependent translational regulation could play a pathological role in FGF-2 expression in vivo, especially in the cardiovascular consequences of diabetes.lld:pubmed
pubmed-article:15289445pubmed:languageenglld:pubmed
pubmed-article:15289445pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15289445pubmed:citationSubsetIMlld:pubmed
pubmed-article:15289445pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15289445pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15289445pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15289445pubmed:statusMEDLINElld:pubmed
pubmed-article:15289445pubmed:monthOctlld:pubmed
pubmed-article:15289445pubmed:issn1530-6860lld:pubmed
pubmed-article:15289445pubmed:authorpubmed-author:RokutanKazuhi...lld:pubmed
pubmed-article:15289445pubmed:authorpubmed-author:BayardFrancis...lld:pubmed
pubmed-article:15289445pubmed:authorpubmed-author:KondoKazumiKlld:pubmed
pubmed-article:15289445pubmed:authorpubmed-author:PratsAnne-Cat...lld:pubmed
pubmed-article:15289445pubmed:authorpubmed-author:ArnalJean-Fra...lld:pubmed
pubmed-article:15289445pubmed:authorpubmed-author:Teshima-Kondo...lld:pubmed
pubmed-article:15289445pubmed:authorpubmed-author:Prado-Lourenc...lld:pubmed
pubmed-article:15289445pubmed:authorpubmed-author:Gonzalez-Herr...lld:pubmed
pubmed-article:15289445pubmed:issnTypeElectroniclld:pubmed
pubmed-article:15289445pubmed:volume18lld:pubmed
pubmed-article:15289445pubmed:ownerNLMlld:pubmed
pubmed-article:15289445pubmed:authorsCompleteYlld:pubmed
pubmed-article:15289445pubmed:pagination1583-5lld:pubmed
pubmed-article:15289445pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15289445pubmed:meshHeadingpubmed-meshheading:15289445...lld:pubmed
pubmed-article:15289445pubmed:meshHeadingpubmed-meshheading:15289445...lld:pubmed
pubmed-article:15289445pubmed:meshHeadingpubmed-meshheading:15289445...lld:pubmed
pubmed-article:15289445pubmed:meshHeadingpubmed-meshheading:15289445...lld:pubmed
pubmed-article:15289445pubmed:meshHeadingpubmed-meshheading:15289445...lld:pubmed
pubmed-article:15289445pubmed:meshHeadingpubmed-meshheading:15289445...lld:pubmed
pubmed-article:15289445pubmed:meshHeadingpubmed-meshheading:15289445...lld:pubmed
pubmed-article:15289445pubmed:meshHeadingpubmed-meshheading:15289445...lld:pubmed
pubmed-article:15289445pubmed:meshHeadingpubmed-meshheading:15289445...lld:pubmed
pubmed-article:15289445pubmed:meshHeadingpubmed-meshheading:15289445...lld:pubmed
pubmed-article:15289445pubmed:meshHeadingpubmed-meshheading:15289445...lld:pubmed
pubmed-article:15289445pubmed:meshHeadingpubmed-meshheading:15289445...lld:pubmed
pubmed-article:15289445pubmed:meshHeadingpubmed-meshheading:15289445...lld:pubmed
pubmed-article:15289445pubmed:year2004lld:pubmed
pubmed-article:15289445pubmed:articleTitleHyperglycemia upregulates translation of the fibroblast growth factor 2 mRNA in mouse aorta via internal ribosome entry site.lld:pubmed
pubmed-article:15289445pubmed:affiliationInstitut National de la Santé et de la Recherche Médicale U589, Hormones, Facteurs de Croissance et Physiopathologie Vasculaire, Institut Louis Bugnard IFR31, Hôpital Rangueil, Toulouse, France.lld:pubmed
pubmed-article:15289445pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15289445pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:14173entrezgene:pubmedpubmed-article:15289445lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15289445lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15289445lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15289445lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15289445lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15289445lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15289445lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15289445lld:pubmed